A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells

Lignende værker

• Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis
  af: Ben-David, Hava, et al.
  Udgivet: (2005)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  af: Paas-Rozner, Miri, et al.
  Udgivet: (2000)
• Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes
  af: Faber-Elmann, Anat, et al.
  Udgivet: (1998)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  af: Aruna, Badiga Venkata, et al.
  Udgivet: (2005)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
  af: Paas-Rozner, Miri, et al.
  Udgivet: (2001)